NCT03910218Completed
Come As You Are - Assessing the Efficacy of a Nurse Case Management HIV Prevention and Care Intervention Among Homeless Youth
Source: ClinicalTrials.gov · Last updated 26 Jun 2025
Brief summary (registry, in English)
The purpose of this study is to to determine the efficacy of the Nurse Case Management HIV (NCM4HIV) intervention on HIV prevention compared to usual care among Youth Experiencing Homelessness (YEH).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 474 (actual)
- First submitted
- 8 Apr 2019
- Start date
- 11 Nov 2019
- Primary completion date
- 3 Apr 2024
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Diseases
- HIV
- NCT number
- NCT03910218
What you commit to
- Study type: Interventional
- Participants enrolled: 474
- From 11 Nov 2019 to the primary completion date, 3 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- youth with very low literacy
- severe acute mental symptoms
Who the study is looking for
- youth engaged in high-risk sexual activity or intravenous drug use
- speak English
- homeless
- not planning to move out of the metro area during the study
Age in the registry: 16 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Health Science Center at Houston Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
Related publications
- Prevalence and characteristics of sex trafficking among youth experiencing homelessness: A cross-sectional study.PLoS One · 2026 · PMID 42647548
This page is information, not medical advice. Discuss any trial with your doctor.